(PDF) A Novel Antibody Targeting ICOS Increases

A Novel Antibody Targeting ICOS Increases Intratumoural Cytotoxic to Regulatory T Cell Ratio and Induces Tumour Regression.

doi 10.1101/771493

Full Text

Abstract

Available in full text

Date

September 16, 2019

Authors

Richard C.A. Sainson

Anil K. Thotakura

Gwenoline Borhis

Simon Henderson

Siobhan O’Leary

Lauriane Gamand

Vivian W. Y. Wong

Robert J. Rowlands

Morgane Lecointre

Volker Germaschewski

Elisabeth Oelmann

Sonia Quaratino

Matthew McCourt

Publisher

Cold Spring Harbor Laboratory

Related search

Antibody Targeting of “Steady-State” Dendritic Cells Induces Tolerance Mediated by Regulatory T Cells

Frontiers in Immunology

English

T Cell Epitope Immunotherapy Induces a CD4+ T Cell Population With Regulatory Activity

Molecular Biology

English

A Novel Regulatory T Cell Population in the Gut

Molecular Biology

Biological Sciences

English

A Novel Bispecific Single-Chain Antibody for ADAM17 and CD3 Induces T-Cell-Mediated Lysis of Prostate Cancer Cells

Biochemical Journal

Molecular Biology

English

BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells

Clinical Cancer Research

Cancer Research

English

ICOS Controls the Pool Size of Effector-Memory and Regulatory T Cells

Journal of Immunology

English

Targeting the Tumour Microenvironment and T Cell Metabolism for Effective Cancer Immunotherapy

European Journal of Immunology

English

Antibody-Mediated Targeting of Cleavage-Specific OPN-T Cell Interactions

Multidisciplinary

English

Intravenous Apoptotic Spleen Cell Infusion Induces a TGF-β-dependent Regulatory T-Cell Expansion

Cell Death and Differentiation

Molecular Biology

English